http://dbpedia.org/ontology/abstract
|
Larazotide (INN; also known as AT-1001; fo … Larazotide (INN; also known as AT-1001; formulated as the salt with acetic acid, larazotide acetate) is a synthetic eight amino acid peptide that functions as a tight junction regulator and reverses leaky junctions to their normally closed state. It is being studied in people with celiac disease.ing studied in people with celiac disease.
|
http://dbpedia.org/ontology/casNumber
|
881851-50-9 (acetate)
, 258818-34-7
|
http://dbpedia.org/ontology/fdaUniiCode
|
ZN3R5560ZV
|
http://dbpedia.org/ontology/kegg
|
D09351
|
http://dbpedia.org/ontology/pubchem
|
9810532
|
http://dbpedia.org/ontology/thumbnail
|
http://commons.wikimedia.org/wiki/Special:FilePath/Larazotide.svg?width=300 +
|
http://dbpedia.org/ontology/wikiPageID
|
50196193
|
http://dbpedia.org/ontology/wikiPageLength
|
8050
|
http://dbpedia.org/ontology/wikiPageRevisionID
|
1092619673
|
http://dbpedia.org/ontology/wikiPageWikiLink
|
http://dbpedia.org/resource/International_nonproprietary_name +
, http://dbpedia.org/resource/Acetic_acid +
, http://dbpedia.org/resource/CXCR3 +
, http://dbpedia.org/resource/Salt_%28chemistry%29 +
, http://dbpedia.org/resource/Protease-activated_receptor_2 +
, http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/Cell_culture +
, http://dbpedia.org/resource/Vibrio_cholerae +
, http://dbpedia.org/resource/Enterotoxin +
, http://dbpedia.org/resource/%3C/nowiki%3E%282%27%27S%27%27%29-1-%5B%282%27%27S%27%27%29-5-amino-2-%3Cnowiki%3E%5B%5B%3C/nowiki%3E%282%27%27S%27%27%29-2-%3Cnowiki%3E%5B%5B%3C/nowiki%3E%282%27%27S%27%27%29-2-%3Cnowiki%3E%5B%5B%3C/nowiki%3E%282%27%27S%27%27%29-2-%3Cnowiki%3E%5B%5B%3C/nowiki%3E2-%5B%282-Aminoacetyl%29amino%5Dacetyl%5Damino%5D-3-methylbutanoyl%5Damino%5D-4-methylpentanoyl%5Damino%5D-3-methylbutanoyl%5Damino%5D-5-oxopentanoyl%5Dpyrrolidine-2-carbonyl%5Damino%5Dacetic_acid +
, http://dbpedia.org/resource/Gliadin +
, http://dbpedia.org/resource/Category:Drugs_acting_on_the_gastrointestinal_system_and_metabolism +
, http://dbpedia.org/resource/Category:Peptides +
, http://dbpedia.org/resource/MYD88 +
, http://dbpedia.org/resource/Peptide +
, http://dbpedia.org/resource/Zonulin +
, http://dbpedia.org/resource/Rheumatoid_arthritis +
, http://dbpedia.org/resource/Chemokine +
, http://dbpedia.org/resource/Epidermal_growth_factor_receptor +
, http://dbpedia.org/resource/Lumen_%28anatomy%29 +
, http://dbpedia.org/resource/Peptide_synthesis +
, http://dbpedia.org/resource/Coeliac_disease +
, http://dbpedia.org/resource/Intestinal_permeability +
, http://dbpedia.org/resource/Gluten_immunochemistry +
, http://dbpedia.org/resource/International_Union_of_Pure_and_Applied_Chemistry +
, http://dbpedia.org/resource/Immune_system +
, http://dbpedia.org/resource/C-terminus +
, http://dbpedia.org/resource/Amino_acid +
, http://dbpedia.org/resource/Tight_junction +
|
http://dbpedia.org/property/c
|
32
|
http://dbpedia.org/property/casNumber
|
258818
|
http://dbpedia.org/property/casSupplemental
|
881851
|
http://dbpedia.org/property/chemspiderid
|
7986288
|
http://dbpedia.org/property/h
|
55
|
http://dbpedia.org/property/iupacName
|
2
|
http://dbpedia.org/property/kegg
|
D09351
|
http://dbpedia.org/property/legalStatus
|
Investigational
|
http://dbpedia.org/property/n
|
9
|
http://dbpedia.org/property/o
|
10
|
http://dbpedia.org/property/pubchem
|
9810532
|
http://dbpedia.org/property/smiles
|
CCC[C@@H]NC[C@H]NCCNCCN
|
http://dbpedia.org/property/stdinchi
|
1
|
http://dbpedia.org/property/stdinchikey
|
ORFLZNAGUTZRLQ-ZMBVWFSWSA-N
|
http://dbpedia.org/property/unii
|
ZN3R5560ZV
|
http://dbpedia.org/property/wikiPageUsesTemplate
|
http://dbpedia.org/resource/Template:Infobox_drug +
, http://dbpedia.org/resource/Template:Reflist +
, http://dbpedia.org/resource/Template:Fdacite +
|
http://purl.org/dc/terms/subject
|
http://dbpedia.org/resource/Category:Peptides +
, http://dbpedia.org/resource/Category:Experimental_drugs +
, http://dbpedia.org/resource/Category:Drugs_acting_on_the_gastrointestinal_system_and_metabolism +
|
http://www.w3.org/ns/prov#wasDerivedFrom
|
http://en.wikipedia.org/wiki/Larazotide?oldid=1092619673&ns=0 +
|
http://xmlns.com/foaf/0.1/depiction
|
http://commons.wikimedia.org/wiki/Special:FilePath/Larazotide.svg +
|
http://xmlns.com/foaf/0.1/isPrimaryTopicOf
|
http://en.wikipedia.org/wiki/Larazotide +
|
owl:sameAs |
http://www.wikidata.org/entity/Q25327025 +
, http://yago-knowledge.org/resource/Larazotide +
, https://global.dbpedia.org/id/2PNUY +
, http://dbpedia.org/resource/Larazotide +
|
rdf:type |
http://dbpedia.org/ontology/ChemicalSubstance +
, http://dbpedia.org/ontology/Drug +
, http://www.wikidata.org/entity/Q8386 +
, http://www.ontologydesignpatterns.org/ont/dul/DUL.owl#ChemicalObject +
|
rdfs:comment |
Larazotide (INN; also known as AT-1001; fo … Larazotide (INN; also known as AT-1001; formulated as the salt with acetic acid, larazotide acetate) is a synthetic eight amino acid peptide that functions as a tight junction regulator and reverses leaky junctions to their normally closed state. It is being studied in people with celiac disease.ing studied in people with celiac disease.
|
rdfs:label |
Larazotide
|